<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03970629</url>
  </required_header>
  <id_info>
    <org_study_id>CEU2018-46K</org_study_id>
    <nct_id>NCT03970629</nct_id>
  </id_info>
  <brief_title>ROSA Total Knee Investigational Testing Authorization Study</brief_title>
  <official_title>ROSA Total Knee Investigational Testing Authorization Study: Prospective Single Center Study of the ROSA Total Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single-center clinical study designed to facilitate the collection and
      evaluation of workflow efficiency, patient pain and function, and adverse event data. This
      clinical study will include Persona Total Knee components using the ROSA Total Knee Robotic
      System or conventional instrumentation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to collect and compare clinical outcomes and surgical
      data using the ROSA Total Knee robotic instrumentation and conventional instrumentation in
      primary total knee arthroplasty.

      The assessments will include: Planned vs actual component positioning; Workflow efficiency;
      Patient safety based on incidence and frequency of adverse events; Clinical performance
      measured by overall pain and function, quality of life data, and radiographic parameters.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 20, 2019</start_date>
  <completion_date type="Anticipated">March 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EQ-5D questionnaire</measure>
    <time_frame>1 year</time_frame>
    <description>EQ-5D</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxford Knee Score Questionnaire</measure>
    <time_frame>1 year</time_frame>
    <description>Oxford Knee Score</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Knee Pain</condition>
  <condition>Chronic Osteoarthritis</condition>
  <condition>Avascular Necrosis of Femoral Condyle</condition>
  <condition>Moderate Varus, Valgus or Flexion Deformities</condition>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Robotic Assisted TKA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Robotic Assisted TKA via ROSA Robot</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional TKA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Conventional TKA</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PERSONA Total Knee</intervention_name>
    <description>Primary Total Knee Arthroplasty</description>
    <arm_group_label>Conventional TKA</arm_group_label>
    <arm_group_label>Robotic Assisted TKA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is a minimum of 18 years of age

          2. Pre-op component positioning and sizing plan prior to surgery

          3. Independent of study participation, patient is a candidate for primary TKA using the
             commercially available Persona knee components implanted in accordance with product
             labeling

          4. Patient has participated in this study-related Informed Consent process

          5. Patient is willing and able to provide written Informed Consent by signing and dating
             the IRB or EC approved Informed Consent form

          6. Patient is willing and able to complete scheduled study procedures and follow-up
             evaluations

        Exclusion Criteria:

          1. Patient is currently participating in any other surgical intervention studies or pain
             management studies

          2. Patient has underwent contralateral UKA or TKA within the last 18 months

          3. Hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head
             with collapse, severe dysplasia of the femoral head or the acetabulum)

          4. Hip pathology severely limiting range of motion (e.g. arthrodesis, severe contracture,
             chronic severe dislocation)

          5. Patient is pregnant or considered a member of a protected population (e.g., prisoner,
             mentally incompetent, etc.)

          6. Patient has previously received partial or total knee arthroplasty for the ipsilateral
             knee
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kacy Arnold</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tory Sears</last_name>
    <phone>5743732125</phone>
    <email>tory.sears@zimmerbiomet.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Maisonneuve-Rosemont</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H1T 2M4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge Marquis</last_name>
      <phone>5142523400</phone>
      <phone_ext>5701</phone_ext>
      <email>smarquis.hmr@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Vincent Masse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>May 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>January 23, 2020</last_update_submitted>
  <last_update_submitted_qc>January 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

